Mark Elliott Boulding insider trades

Open-market stock purchases and sales by Mark Elliott Boulding, EXEC. VP AND CLO at PTC Therapeutics, Inc, from SEC Form 4 filings since Jan 28, 2014.

Recent trades

DateStockTradeValue
Oct 9, 2026PTCT PTC Therapeutics, IncSold$12.3K
Oct 9, 2026PTCT PTC Therapeutics, IncBought (not open market)$7.6K
Oct 9, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Oct 6, 2026PTCT PTC Therapeutics, IncSold$27.9K
Oct 6, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Oct 5, 2026PTCT PTC Therapeutics, IncSold$105K
Oct 5, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Aug 17, 2026PTCT PTC Therapeutics, IncSold$133K
Aug 17, 2026PTCT PTC Therapeutics, IncSold$70.6K
Aug 17, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Jul 6, 2026PTCT PTC Therapeutics, IncSold$44.6K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$51.9K
Jul 6, 2026PTCT PTC Therapeutics, IncBought (not open market)$89.3K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$26K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$32.2K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$87.4K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$55.4K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$64.4K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$70.3K
Jul 6, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Jul 6, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Jun 17, 2026PTCT PTC Therapeutics, IncSold$518K
Jun 17, 2026PTCT PTC Therapeutics, IncSold$147K
Jun 17, 2026PTCT PTC Therapeutics, IncSold$134K
Jun 17, 2026PTCT PTC Therapeutics, IncSold$24.5K

Companies traded

  • PTCT PTC Therapeutics, Inc: 170 sales, last Oct 9, 2026

Get free alerts when Mark Elliott Boulding files a new trade →